Poor uptake of hepatitis B vaccine in India has several causes, study finds

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f3596 (Published 6 June 2013)
Cite this as: BMJ 2013;346:f3596

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Cheryl Travasso
  1. 1Mumbai

Poor management of vaccine stocks, poor record keeping, lack of staff training, and use of multidose vials were among the main reasons for low coverage of the hepatitis B vaccine in 10 states across India, researchers have found.

India is home to 11% of the world’s people with chronic hepatitis B and has between 100 000 and 200 000 deaths from hepatocellular carcinoma or cirrhosis each year. To tackle the disease, India introduced the hepatitis B vaccine across 10 states in …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL